DOCSLIB.ORG

Supplementary Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Material Supplementary material Olgert Denas September 24, 2014 List of Figures 1 Workflow of data and experiments. .3 2 The number of TFos for all human and mouse cell types mapped by each of the considered whole genome alignments . .4 3 For each human celltype-factor pair we tested whether the SeqCons rate (of all TFos how many are SeqCons) is higher than expected by a Binomial test . .5 4 For each mouse celltype-factor pair we tested whether the SeqCons rate (of all TFos how many are SeqCons) is higher than expected by a Binomial test . .6 5 The distribution of mouse mappable TFos across cell types ...............7 6 The distribution of human mappable TFos across cell types ..............8 7 The distribution of mouse mappable TFos across transcription factors ........9 8 The distribution of human mappable TFos across transcription factors ........ 10 9 The distribution of mouse mappable TFos nucleotides across cell types ........ 11 10 The distribution of human mappable TFos nucleotides across cell types ........ 12 11 The distribution of mouse mappable TFos nucleotides across transcription factors .. 13 12 The distribution of human mappable TFos nucleotides across transcription factors . 14 13 For each celltype-factor pair we tested whether the (log) binding signal over Funct- Cons or FunctActive elements was significantly different from that over SeqCons elements . 15 14 For each celltype-factor pair we tested whether the (log) binding signal over Funct- Cons or FunctActive elements was significantly different from that over SeqCons elements . 16 15 Classification of mappable elements for all three analogous cell types . 17 16 Classification of mappable elements for all three analogous cell types . 18 17 The plot shows the number of FunctActive elements from a query assay as a function of the subset size . 19 18 The plot shows the number of FunctActive elements from a query assay with respect to a subset of assays from the other species . 20 19 We modeled the situation of a set of assays that have no co-association, thus overlap with an exclusive set of TFos on the other species . 21 20 A mouse Rad21 occupancy site mapped on human chromosome 20. Mapping is guided by the human-mouse whole genome alignments which report 5 insertions in human. We classified this mouse TFos as FunctCons, as its mapped version in human overlapps with Rad21 occupancy sites in K562. 22 List of Tables 1 Peak signal statistics by peak classes . 23 2 Analogous cells . 23 3 Counts of mappable, functionally active, and total TFos. The table reports both the element count and the coverage in mega bases . 24 4 Number of TFos mapped by each alignment for select assays. An element can be mapped if it overlaps DHS elements and shared human mouse DNA by half of its length. 24 1 5 Number of TFos mapped by each alignment for select assays. An element can be mapped if it overlaps DHS elements and shared human mouse DNA by half of its length. Continues ... 25 6 Number of TFos mapped by each alignment for select assays. An element can be mapped if it overlaps DHS elements and shared human mouse DNA by half of its length. 26 2 1 Supplementary figures Figure 1: Workflow of data and experiments. 3 Wi38 Werirb1 U87 U2os T47d Sknshra Sknsh Sknmc Shsy5y Saec Rptec Raji Pfsk1 Pbdefetal Pbde Panc1 Nt2d1 Nhlf Nhek Nhdfneo Nb4 Mcf7 Mcf10aes K562 Imr90 Hvmf Huvec Hrpe Hre Hpf Hpaf Hmf Hmec Hl60 Hffmyc Hff Hepg2 Helas3 Hek293t Hek293 Hee Hct116 Hcpe Hcm Hcfaa Hbmec Hasp item_class Hac H1hesc Gm19193 Gm19099 epo Gm18951 Gm18526 Gm18505 Gm15510 shared Gm12892 Gm12891 Gm12878 Gm12875 ucsc Gm12874 Gm12873 Gm12872 Gm12865 Gm12864 Gm12801 Gm10847 Gm08714 Cell type (hg19 and mm9) Gm06990 Ecc1 Caco2 Bj Be2c Aoaf Ag10803 Ag09319 Ag09309 Ag04450 Ag04449 A549 Wbrain Thymus Testis Spleen Smint Olfact Mel Megakaryo Mef Lung Liver Limb Kidney Heart G1eer4e2 G1eer4 G1e Ese14 Esb4 Erythrobl Cortex Ch12 Cbellum Bmdm Bmarrow 0e+00 2e+05 4e+05 6e+05 element count Figure 2: The number of TFos for all human and mouse cell types mapped by each of the considered whole genome alignments. Here we show, only those TFos that overlap by half their length with a DHS peak. See supplementary Table 4 for more details. 4 1.00 0.75 significant TRUE 0.50 FALSE 0.25 0.00 0 200 400 1:nrow(a) Figure 3: For each human celltype-factor pair we tested whether the SeqCons rate (of all TFos how many are SeqCons) is higher than expected by a Binomial test. The vertical lines show the estimated 99% confidence interval and the black line indicates the expected rate. The color of the vertical lines indicates whether the interval contains the expected value. 5 0.8 significant TRUE 0.6 0.4 0 40 80 120 1:nrow(a) Figure 4: For each mouse celltype-factor pair we tested whether the SeqCons rate (of all TFos how many are SeqCons) is higher than expected by a Binomial test. The vertical lines show the estimated 99% confidence interval and the black line indicates the expected rate. The color of the vertical lines indicates whether the interval contains the expected value. 6 Wbrain Thymus Olfact Heart Cbellum Megakaryo Smint Limb Cortex Ch12 Spleen Mef Lung Cell Bmdm Liver Testis Bmarrow Mel Kidney G1eer4 Erythrobl Ese14 Esb4 G1eer4e2 G1e 0.7 0.8 0.9 Fraction of elements Figure 5: The distribution of mouse mappable TFos across cell types. The box-plot for each cell type summarizes the distribution of values for the fraction of elements that can be mapped on the other species. Occupied segments for each cell type contribute one value to the distribution. 7 Hek293 Nt2d1 Pfsk1 Sknsh Hct116 Raji U87 Sknmc Hek293t Panc1 Gm10847 Shsy5y Gm15510 Pbdefetal Helas3 H1hesc Pbde Gm12892 Gm18526 Gm18951 Gm18505 Gm19099 Gm19193 A549 Hepg2 Mcf7 Gm12878 Gm12891 Ecc1 Nb4 Gm12801 Huvec Sknshra Nhlf Mcf10aes Hff Wi38 Ag04450 Hac Nhdfneo Cell T47d Ag09309 Hcm K562 Hre Bj Hee Hffmyc Ag10803 Ag09319 Hpf Imr90 Hmf Hasp Gm06990 Hpaf Hvmf Nhek Hmec Hcfaa Aoaf Hl60 Hrpe Gm12874 Gm12865 Be2c Ag04449 Gm12875 Gm12872 Saec Gm12864 Hbmec Hcpe Caco2 Gm12873 Rptec Werirb1 U2os Gm08714 0.5 0.6 0.7 0.8 0.9 Fraction of elements Figure 6: The distribution of human mappable TFos across cell types. The box-plot for each cell type summarizes the distribution of values for the fraction of elements that can be mapped on the other species. 8 Ubfsc13125 Maz Gnc5 Mazab85725 Ubf Gcn5 Fli1sc356 Sin3anb6001263 Pol2 Chd1 Hcfc1 Hcfc1nb10068209 Sin3a Mxi1af4185 Nelfe E2f4 Znfmizdcp1ab65767 Chd1nb10060411 Corestsc30189 Chd2ab68301 Znfmizdcp1 Max Gata2sc9008 Pax5c Usf2 Bhlhe40nb100 Pol2s2 Tf Cmybsc7874 Cmybh141 Zkscan1hpa006672 Ets1 Cjun Nrf2 Bhlhe40 Cmyc Tbp Zc3h11anb10074650 P300sc584 Gata1a Zkscan1 Corest Znf384hpa004051 Jund P300 Tal1 Ctcf Smc3ab9263 Rad21 Znf384 Gata1 Mafkab50322 Ctcfb Pol24h8 Ctcfsc15914 Mafk 0.6 0.7 0.8 0.9 Fraction of elements Figure 7: The distribution of mouse mappable TFos across transcription factors. The box-plot for each transcription factor summarizes the distribution of values for the fraction of elements that can be mapped on the other species. 9 Grp20 Suz12 Ctbp2 Irf3 E2f1 Spt20 Cebpz Brca1a300 Hae2f1 Sin3anb6001263 Hmgn3 Elk4 E2f4 Nfya Ccnt2 Sin3ak20 Chd1a301218a Mazab85725 Sp2 Nrf1 Sp2sc643 Taf1 Mxi1 Chd2 Ubfsc13125 Yy1c Elk112771 Srebp1 Baf170 Foxp2 Ubtfsab1404509 Creb1sc240 Tcf7l2 Mxi1af4185 Brca1 Baf155 Pol2 Sp4v20 Gata3sc269sc269 Gtf2f1 Tr4 Yy1sc281 Ini1 Brg1 Chd2ab68301 Gtf2b E2f6 Six5 P300sc582 Ets1 Gabp Corestsc30189 Zkscan1hpa006672 Egr1 Ap2alpha Tcf7l2c9b92565 Tbp Taf7sc101167 Zbtb7a Gtf2f1ab28179 Rfx5200401194 Cebpdsc636 Max Zbtb7asc34508 Ap2gamma Pol24h8 Cmyc Pgc1a Sp1 Pmlsc71910 Kap1 Yy1 Nrsf Bhlhe40 Irf1 Stat1 Znf263 Whip Nfyb Erra Atf3 Ehdac8 Thap1sc98174 Znf143166181ap Mybl2sc81192 Rxra Gata3 Nelfe Hdac2sc6296 Elf1sc631 P300 Bclaf101388 Pol2s2 Zeb1sc25388 Gata1 Mbd4sc271530 Bhlhe40c Zbtb33 Ikzf1iknucla Tblr1ab24550 Nfkb Nanogsc33759 Bach1 Elf1 Tf Gata3sc269 Arid3anb100279 Atf2sc81188 Gr Egata2 Stat2 Znf217 Fosl1sc183 Gata2 Srf Usf1sc8983 Eralphaa Tblr1nb600270 Mta3sc81325 Hnf4a Tcf12 Nficsc81335 Bhlhe40nb100 Foxm1sc502 Tcf3 Corestab24166 Nfe2sc22827 Eraa Mef2csc13268 Gata3sc268 Stat3 Pou2f2 P300b Enr4a1 Znf143 Cfos Hnf4gsc6558 Usf2 Pbx3 Ejunb Smc3ab9263 Cjun Ejund Prdm19115 Stat5asc74442 P300sc584sc584 Pax5n19 Foxa1sc6553 Bach1sc14700 Nfatc1sc17834 Mef2a Nr2f2sc271940 Arid3asc8821 Ctcf Tead4sc101184 Atf106325 Rad21 Zzz3 Ctcfb Ebf1sc137065 Jund Foxa1 Ctcfc Bcl3 Pax5c20 Ctcfsc15914c20 Hnf4asc8987 Efos Ctcflsc98982 Cbx3sc101004 Irf4sc6059 Mafk Trim28sc81411 Foxa1sc101058 Fosl2 Runx3sc101553 Foxa2sc6554 Ctcfsc5916 Bcl11a Maffm8194 Mafksc477 Usf1 Rfx5 Cebpb Mafkab50322 Pu1 Maff Cebpbsc150 Sirt6 Srebp2 Tal1sc12984 Nfe2 Pou5f1sc9081 Batf Gcn5 Gata2sc267 Esr Hsf1 Znf274m01 Setdb1 Brf2 Znf274 Tf3c110 Rpc155 Bdp1 Brf1 Pol3 0.25 0.50 0.75 Fraction of elements Figure 8: The distribution of human mappable TFos across transcription factors. The box-plot for each transcription factor summarizes the distribution of values for the fraction of elements that can be mapped on the other species. 10 Wbrain Thymus Olfact Heart Cbellum Megakaryo Smint Cortex Ch12 Mef Limb Lung Liver Cell Bmdm Spleen Bmarrow Testis Mel Kidney Erythrobl Esb4 G1eer4 Ese14 G1eer4e2 G1e 0.60 0.65 0.70 0.75 0.80 0.85 Fraction of bases Figure 9: The distribution of mouse mappable TFos nucleotides across cell types. The box-plot for each cell type summarizes the distribution of values for the fraction of nucleotides that can be mapped on the other species. 11 Nt2d1 Hek293 Sknsh Pfsk1 Shsy5y Hct116 Sknmc U87 H1hesc Raji Hek293t Gm10847 Gm12892 Panc1 Helas3 Gm15510 Pbdefetal Gm18526 Pbde Gm18951 A549 Ecc1 Gm19099 Hepg2 Gm18505 Gm19193 Sknshra Huvec Mcf7 Mcf10aes Gm12878 Gm12891 Nb4 T47d Nhlf K562 Hff Hac Gm12801 Nhdfneo Cell Hcm Ag04450 Imr90 Bj Wi38 Ag09319 Hre Hffmyc Ag10803 Ag09309 Hee Hpf Hpaf Nhek Hvmf Hmec Hasp Ag04449 Aoaf Hmf Hcfaa Be2c Saec Gm06990 Hrpe Hcpe Hbmec Gm12874 Gm12865 Rptec Gm12872 Gm12864 Gm12875 Hl60 Gm12873 Caco2 U2os Werirb1 Gm08714 0.5 0.6 0.7 Fraction of bases Figure 10: The distribution of human mappable TFos nucleotides across cell types.
Load more

Recommended publications
  • MOZ and MORF, Two Large Mystic Hats in Normal and Cancer Stem Cells
    Oncogene (2007) 26, 5408–5419 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells X-J Yang and M Ullah Molecular Oncology Group, Department of Medicine, McGill University Health Center, Montre´al, Que´bec, Canada Genes of the human monocytic leukemia zinc-finger protein pattern. For cancer biology, it is thus important to MOZ (HUGO symbol, MYST3) and its paralog MORF understand the fundamental mechanisms whereby chro- (MYST4) are rearranged in chromosome translocations matin structure and function are regulated. In the associated withacute myeloid leukemia and/or benign past two decades, our knowledge about regulation in uterine leiomyomata. Both proteins have intrinsic histone this field has exploded. Known regulatory mechanisms acetyltransferase activity and are components of quartet include chromatin assembly, ATP-dependent remodeling, complexes withnoncatalytic subunits containing thebromo- covalent modification, condensin-mediated condensation, domain, plant homeodomain-linked (PHD) finger and replacement with histone variants, and association of proline-tryptophan-tryptophan-proline (PWWP)-containing noncoding RNA (reviewed by Horn and Peterson, 2002; domain, three types of structural modules characteristic of Khorasanizadeh, 2004; Li et al., 2007). Covalent chromatin regulators. Although leukemia-derived fusion pro- modification can occur at both the DNA and histone teins suchas MOZ-TIF2 promote self-renewal of leukemic levels. With histones, modifications include acetylation, stem cells, recent studies indicate that murine MOZ and phosphorylation, methylation, ubiquitination, and many MORF are important for proper development of hema- others (for reviews, see Spencer and Davie, 1999; Strahl topoietic and neurogenic progenitors, respectively, thereby and Allis, 2000; Berger, 2002; Jason et al., 2002; highlighting the importance of epigenetic integrity in Kouzarides, 2007).
    [Show full text]
  • Genome-Wide Profiling of Active Enhancers in Colorectal Cancer
    Genome-wide proling of active enhancers in colorectal cancer Min Wu ( [email protected] ) Wuhan University https://orcid.org/0000-0003-1372-4764 Qinglan Li Wuhan University Xiang Lin Wuhan University Ya-Li Yu Zhongnan Hospital, Wuhan University Lin Chen Wuhan University Qi-Xin Hu Wuhan University Meng Chen Zhongnan Hospital, Wuhan University Nan Cao Zhongnan Hospital, Wuhan University Chen Zhao Wuhan University Chen-Yu Wang Wuhan University Cheng-Wei Huang Wuhan University Lian-Yun Li Wuhan University Mei Ye Zhongnan Hospital, Wuhan University https://orcid.org/0000-0002-9393-3680 Article Keywords: Colorectal cancer, H3K27ac, Epigenetics, Enhancer, Transcription factors Posted Date: December 10th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-119156/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Genome-wide profiling of active enhancers in colorectal cancer Qing-Lan Li1, #, Xiang Lin1, #, Ya-Li Yu2, #, Lin Chen1, #, Qi-Xin Hu1, Meng Chen2, Nan Cao2, Chen Zhao1, Chen-Yu Wang1, Cheng-Wei Huang1, Lian-Yun Li1, Mei Ye2,*, Min Wu1,* 1 Frontier Science Center for Immunology and Metabolism, Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of Developmentally Originated Disease, Hubei Key Laboratory of Intestinal and Colorectal Diseases, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China 2Division of Gastroenterology, Department of Geriatrics, Hubei Clinical Centre & Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430072, China #Equal contribution to the study. Contact information *Correspondence should be addressed to Dr. Min Wu, Email: [email protected], Tel: 86-27-68756620, or Dr.
    [Show full text]
  • The Basic Region and Leucine Zipper Transcription Factor Mafk Is a New Nerve Growth Factor-Responsive Immediate Early Gene That Regulates Neurite Outgrowth
    The Journal of Neuroscience, October 15, 2002, 22(20):8971–8980 The Basic Region and Leucine Zipper Transcription Factor MafK Is a New Nerve Growth Factor-Responsive Immediate Early Gene That Regulates Neurite Outgrowth Be´ ata To¨ro¨ csik, James M. Angelastro, and Lloyd A. Greene Department of Pathology and Center for Neurobiology and Behavior, Columbia University College of Physicians and Surgeons, New York, New York 10032 We used serial analysis of gene expression to identify new mediated by an atypical isoform of PKC but not by mitogen- NGF-responsive immediate early genes (IEGs) with potential activated kinase kinase, phospholipase C␥, or phosphoinositide roles in neuronal differentiation. Among those identified was 3Ј-kinase. Interference with MafK expression or activity by small MafK, a small Maf family basic region and leucine zipper tran- interfering RNA and dominant negative strategies, respectively, scriptional repressor and coactivator expressed in immature suppresses NGF-promoted outgrowth and maintenance of neu- neurons. NGF treatment elevates the levels of both MafK tran- rites by PC12 cells and neurite outgrowth by immature telence- scripts and protein. In contrast, there is no effect on expression phalic neurons. Our findings support a role for MafK as a novel of the closely related MafG. Unlike many other NGF-responsive regulator of neuronal differentiation. IEGs, MafK regulation shows selectivity and is unresponsive to epidermal growth factor, depolarization, or cAMP derivatives. Key words: MafK; NGF; immediate early
    [Show full text]
  • Human Small Maf Proteins Form Heterodimers with CNC Family Transcription Factors and Recognize the NF-E2 Motif
    Oncogene (1997) 14, 1901 ± 1910 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif Tsutomu Toki1, Jugou Itoh2, Jun'ichi Kitazawa1, Koji Arai1, Koki Hatakeyama3, Jun-itsu Akasaka4, Kazuhiko Igarashi5, Nobuo Nomura6, Masaru Yokoyama1, Masayuki Yamamoto5 and Etsuro Ito1 1Department of Pediatrics, 2Medicine, School of Medicine; 3Department of Biology, Faculty of Sciences, Hirosaki University, Hirosaki 036; 4Department of Biochemistry, Tohoku University School of Medicine, Sendai 980-77; 5Center for TARA and Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba 305; 6Kazusa DNA Institute, Kisarazu 292, Japan The transcription factor NF-E2, a heterodimeric protein Talbot et al., 1990; Talbot and Grosveld, 1991; complex composed of p45 and small Maf family Kotkow and Orkin, 1995). Recent analyses demon- proteins, is considered crucial for the regulation of strated that NF-E2 is composed of two subunits erythroid gene expression and platelet formation. To (Andrews et al., 1993a,b; Igarashi et al., 1994). The facilitate the characterization of NF-E2 functions in large p45 subunit belongs to a family of basic leucine- human cells, we isolated cDNAs encoding two members zipper (bZip) proteins that is closely related to the of the small Maf family, MafK and MafG. The human Drosophila Cap`n'colar (the CNC family) factor mafK and mafG genes encode proteins of 156 and 162 (Mohler et al., 1991). It cannot bind to the NF-E2 amino acid residues, respectively, whose deduced amino sequence as a homodimer, but does do after forming acid sequences show approximately 95% identity to their heterodimers with chicken small Maf family proteins, respective chicken counterparts.
    [Show full text]
  • Heterogeneous Nuclear Ribonucleoprotein C1 C2, Mecp1
    Heterogeneous nuclear ribonucleoprotein C1͞C2, MeCP1, and SWI͞SNF form a chromatin remodeling complex at the ␤-globin locus control region Milind C. Mahajan*, Geeta J. Narlikar†, Gokul Boyapaty*, Robert E. Kingston‡, and Sherman M. Weissman*§ *Department of Genetics, The Anlyan Center, Yale University School of Medicine, New Haven, CT 06511; †Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143; and ‡Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 Contributed by Sherman M. Weissman, August 31, 2005 Locus control regions (LCRs) are regulatory DNA sequences that are promoter (20–23). These studies suggest the possible association situated many kilobases away from their cognate promoters. LCRs of the LCR with specific chromatin remodeling activities, al- protect transgenes from position effect variegation and hetero- though such a LCR-specific chromatin remodeling activity has chromatinization and also promote copy-number dependence of not been isolated. In the present work, we describe the biochem- the levels of transgene expression. In this work, we describe the ical purification and properties of a previously undescribed biochemical purification of a previously undescribed LCR-associ- chromatin-remodeling complex that binds to the human ␤-globin ated remodeling complex (LARC) that consists of heterogeneous LCR HS2 in a sequence-specific manner. nuclear ribonucleoprotein C1͞C2, nucleosome remodeling SWI͞ SNF, and nucleosome remodeling and deacetylating (NuRD)͞ Materials and Methods MeCP1 as a single homogeneous complex. LARC binds to the Cell Culture and Preparation of Nuclear Extracts. Growth of the K562 hypersensitive 2 (HS2)-Maf recognition element (MARE) DNA in a cells and preparation of the nuclear extract is described in ref.
    [Show full text]
  • The Chemical Defensome of Five Model Teleost Fish
    www.nature.com/scientificreports OPEN The chemical defensome of fve model teleost fsh Marta Eide1,5, Xiaokang Zhang2,3,5, Odd André Karlsen1, Jared V. Goldstone4, John Stegeman4, Inge Jonassen2 & Anders Goksøyr1* How an organism copes with chemicals is largely determined by the genes and proteins that collectively function to defend against, detoxify and eliminate chemical stressors. This integrative network includes receptors and transcription factors, biotransformation enzymes, transporters, antioxidants, and metal- and heat-responsive genes, and is collectively known as the chemical defensome. Teleost fsh is the largest group of vertebrate species and can provide valuable insights into the evolution and functional diversity of defensome genes. We have previously shown that the xenosensing pregnane x receptor (pxr, nr1i2) is lost in many teleost species, including Atlantic cod (Gadus morhua) and three-spined stickleback (Gasterosteus aculeatus), but it is not known if compensatory mechanisms or signaling pathways have evolved in its absence. In this study, we compared the genes comprising the chemical defensome of fve fsh species that span the teleosteii evolutionary branch often used as model species in toxicological studies and environmental monitoring programs: zebrafsh (Danio rerio), medaka (Oryzias latipes), Atlantic killifsh (Fundulus heteroclitus), Atlantic cod, and three-spined stickleback. Genome mining revealed evolved diferences in the number and composition of defensome genes that can have implication for how these species sense and respond to environmental pollutants, but we did not observe any candidates of compensatory mechanisms or pathways in cod and stickleback in the absence of pxr. The results indicate that knowledge regarding the diversity and function of the defensome will be important for toxicological testing and risk assessment studies.
    [Show full text]
  • NF-E2p18/Mafk Is Required in DMSO-Induced Differentiation Of
    Leukemia (1997) 11, 273–280 1997 Stockton Press All rights reserved 0887-6924/97 $12.00 NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity C Francastel, V Poindessous-Jazat, Y Augery-Bourget and J Robert-Le´ze´ne`s INSERM U268, Hoˆpital Paul Brousse, 94800 Villejuif, France When Friend murine erythroleukemia (F-MEL) cells are induced (LCR).6 The b-globin complex LCR (b-LCR) include four to differentiate by dimethylsulfoxide (DMSO), erythroid-specific erythroid-specific DNasel hypersensitive sites (designated HS- genes are transcriptionally activated. The erythroid transcrip- 1 to HS-4) and acts as a powerful enhancer of transcription tion factor NF-E2 is essential for enhancer activity of the globin 7,8 locus control regions. NF-E2 functions as a heterocomplex of globin promoters. While all four HS have LCR activity in consisting of a 45-kDa subunit (NF-E2p45) and a 18-kDa sub- transgenic mice, only one region (HS-2) is crucial for unit (NF-E2p18). The larger subunit NF-E2p45 is tissue-restric- enhancer activity when assayed in transient transfection ted and is believed to play a role in globin gene expression in systems.9–11 Within HS-2, the enhancer activity for globin F-MEL cells. The expression of the smaller subunit NF-E2p18, expression requires a tandem repeat of AP-1-like which is a Maf family member (MafK), is cell type- and develop- 12,13 mental stage-specific. We have investigated the possible role elements. This tandem motif was shown to bind two tran- of NF-E2p18 in Friend erythroid differentiation by stably trans- scription factors: the ubiquitous AP-1 protein and the lineage fecting either sense and antisense p18 constructs into differen- limited NF-E2 protein.14,15 The NF-E2 complex is a hetero- tiation-sensitive 745A and partially defective-differentiation dimer of two b-Zip proteins of 45 and 18 kDa.16,17 While NF- TFP10 cell lines.
    [Show full text]
  • JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?
    International Journal of Molecular Sciences Review JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation? Gerhild Euler 1,* , Jens Kockskämper 2, Rainer Schulz 1 and Mariana S. Parahuleva 3 1 Institute of Physiology, Justus Liebig University, 35392 Giessen, Germany; [email protected] 2 Biochemical-Pharmacological Centre (BPC) Marburg, Institute of Pharmacology and Clinical Pharmacy, University of Marburg, 35043 Marburg, Germany; [email protected] 3 Internal Medicine/Cardiology and Angiology, University Hospital of Giessen and Marburg, 35033 Marburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-0641-9947246; Fax: +49-0641-9947219 Abstract: Heart failure (HF) and atrial fibrillation (AF) are two major life-threatening diseases worldwide. Causes and mechanisms are incompletely understood, yet current therapies are unable to stop disease progression. In this review, we focus on the contribution of the transcriptional modulator, Jun dimerization protein 2 (JDP2), and on HF and AF development. In recent years, JDP2 has been identified as a potential prognostic marker for HF development after myocardial infarction. This close correlation to the disease development suggests that JDP2 may be involved in initiation and progression of HF as well as in cardiac dysfunction. Although no studies have been done in humans yet, studies on genetically modified mice impressively show involvement of JDP2 in HF and AF, making it an interesting therapeutic target. Citation: Euler, G.; Kockskämper, J.; Keywords: heart failure; atrial fibrillation; transcription factor; remodeling Schulz, R.; Parahuleva, M.S. JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation? Int.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • Conditional Expression of the Ubiquitous Transcription Factor
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 7445-7449, August 1995 Biochemistry Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation (erythroid/NF-E2/maf) KAZUHIKO IGARASHI*, KEN ITOH*, NORIo HAYASHI*, MAKOTO NISHIZAWAt, AND MASAYUKI YAMAMOTO* *Department of Biochemistry, Tohoku University School of Medicine, 2-1 Seiryomachi, Aoba-ku, Sendai 980-77; and tDepartment of Molecular Oncology, Kyoto University School of Medicine, Yoshida-Konoecho, Sakyo-ku, Kyoto 606, Japan Communicated by Irving M Klotz, Northwestern University, Evanston, IL, March 20, 1995 ABSTRACT Transcription factor NF-E2 activity is expression accompanying the in vitro differentiation of eryth- thought to be crucial for the transcriptional regulation of roleukemia cells. One of the key mediators appears to be many erythroid-specific genes. The three small Maf family NF-E2, since during such induced differentiation, both DNA proteins (MafF, MafG, and MafK) that are closely related to binding activity to, and enhancer activities of, NF-E2 sites the c-Maf protooncoprotein constitute half of the NF-E2 increase (15-20). However, the level of p45 RNA does not activity by forming heterodimers with the large tissue- change significantly during DMSO-induced MEL cell differ- restricted subunit of NF-E2 called p45. We have established entiation (21). These observations suggested that hetero- and characterized murine erythroleukemia cells that condi- dimeric partners of p45 (i.e., the small Maf family proteins) tionally overexpress MafK from a metallothionein promoter. might be limiting in MEL cells prior to DMSO treatment. The conditional expression of MafK caused accumulation of To analyze the potential regulatory role of the small Maf hemoglobin, an indication of terminal differentiation along family proteins during erythroid differentiation, we prepared the erythroid pathway.
    [Show full text]
  • Engineered Type 1 Regulatory T Cells Designed for Clinical Use Kill Primary
    ARTICLE Acute Myeloid Leukemia Engineered type 1 regulatory T cells designed Ferrata Storti Foundation for clinical use kill primary pediatric acute myeloid leukemia cells Brandon Cieniewicz,1* Molly Javier Uyeda,1,2* Ping (Pauline) Chen,1 Ece Canan Sayitoglu,1 Jeffrey Mao-Hwa Liu,1 Grazia Andolfi,3 Katharine Greenthal,1 Alice Bertaina,1,4 Silvia Gregori,3 Rosa Bacchetta,1,4 Norman James Lacayo,1 Alma-Martina Cepika1,4# and Maria Grazia Roncarolo1,2,4# Haematologica 2021 Volume 106(10):2588-2597 1Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 2Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 3San Raffaele Telethon Institute for Gene Therapy, Milan, Italy and 4Center for Definitive and Curative Medicine, Stanford School of Medicine, Stanford, CA, USA *BC and MJU contributed equally as co-first authors #AMC and MGR contributed equally as co-senior authors ABSTRACT ype 1 regulatory (Tr1) T cells induced by enforced expression of interleukin-10 (LV-10) are being developed as a novel treatment for Tchemotherapy-resistant myeloid leukemias. In vivo, LV-10 cells do not cause graft-versus-host disease while mediating graft-versus-leukemia effect against adult acute myeloid leukemia (AML). Since pediatric AML (pAML) and adult AML are different on a genetic and epigenetic level, we investigate herein whether LV-10 cells also efficiently kill pAML cells. We show that the majority of primary pAML are killed by LV-10 cells, with different levels of sensitivity to killing. Transcriptionally, pAML sensitive to LV-10 killing expressed a myeloid maturation signature.
    [Show full text]
  • A MAFG-Lncrna Axis Links Systemic Nutrient Abundance to Hepatic Glucose Metabolism
    ARTICLE https://doi.org/10.1038/s41467-020-14323-y OPEN A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism Marta Pradas-Juni et al.# Obesity and type 2 diabetes mellitus are global emergencies and long noncoding RNAs (lncRNAs) are regulatory transcripts with elusive functions in metabolism. Here we show that a high fraction of lncRNAs, but not protein-coding mRNAs, are repressed during diet-induced 1234567890():,; obesity (DIO) and refeeding, whilst nutrient deprivation induced lncRNAs in mouse liver. Similarly, lncRNAs are lost in diabetic humans. LncRNA promoter analyses, global cistrome and gain-of-function analyses confirm that increased MAFG signaling during DIO curbs lncRNA expression. Silencing Mafg in mouse hepatocytes and obese mice elicits a fasting-like gene expression profile, improves glucose metabolism, de-represses lncRNAs and impairs mammalian target of rapamycin (mTOR) activation. We find that obesity-repressed LincIRS2 is controlled by MAFG and observe that genetic and RNAi-mediated LincIRS2 loss causes elevated blood glucose, insulin resistance and aberrant glucose output in lean mice. Taken together, we identify a MAFG-lncRNA axis controlling hepatic glucose metabolism in health and metabolic disease. #A full list of authors and their affiliations appears at the end of the paper. NATURE COMMUNICATIONS | (2020) 11:644 | https://doi.org/10.1038/s41467-020-14323-y | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14323-y ellular and organism-level energy homeostasis and nutri- by MAFG and CRISPR–Cas9-mediated knockout, or antisense- Cent partitioning are instrumental for survival. In higher mediated RNA interference of LincIRS2 causes hyperglycemia, organisms, multi-organ systems evolved to react to shifts insulin resistance, likely caused by alterations in glucogenic in energy supply by storing (anabolic) or metabolizing (catabolic) gene expression in lean mice.
    [Show full text]